Ecofibre Ltd (eof) Logo

Ecofibre Ltd (EOF)

___:___ · Healthcare

EOF Chart


EOF's Principal Activity is the breeding, growing, processing and distributing hemp products.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -38.99%
vs ASX 200 (1yr) -42.24%


Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 910 of 2,413
Sector Rank 63 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies 4DX / ONE / CYC
EPS -$0.025
DPS $0.00
Book Value Per Share $0.33

Broker Consensus

EOF is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Corporate Overview

Ecofibre Limited (EOF) is focused on selectively owning or controlling specific parts of the hemp value chain, in targeted geographies. EOF sells hemp-based products to consumers, wholesalers and manufacturers.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Sydney NSW 2000
Registry Link Market Services
Auditor William Buck (QLD)
Date Listed 29 Mar 2019

Upcoming Calendar (Forecasted)

Date Event
02/08/2022 Report (Prelim)
18/08/2022 Report (Annual)
23/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Ms Michele Anderson Non-Executive Director Mar 2022

Ms Michele Anderson

Non-Executive Director

Ms Anderson has executive career spans 30 years as an operating business executive, independent director and founder working across the technology, wine and professional services sectors. She has experience across a range of industries in the United States, including leadership of e-commerce and bricks-and-mortar retail businesses. Her leadership contributions in developing and implementing growth strategy, scaling brands and businesses, driving digital growth and transformation, and supporting positive environmental impact and de-carbonisation. She began her career in Australia as a management consultant with Booz Allen and Hamilton and then spent most of her career to date working in the US, including running Shutterfly's consumer ecommerce business in Silicon Valley and Staples' Print and Marketing Services business. Michele also has experience founding and scaling businesses in the highly regulated wine and alcoholic beverages industry. She is an independent director of one of the wine businesses, Baron Philippe de Rothschild, SA.

Ms Vanessa Miscamble Wallace Non-Executive Deputy Chairman,Non-Executive Director Jul 2021

Ms Vanessa Miscamble Wallace

Non-Executive Deputy Chairman,Non-Executive Director

Ms Wallace is an experienced director and has gained experience working as a director of listed and non-listed companies including Wesfarmers Ltd, SEEK Ltd, Doctor Care Anywhere PLC and Palladium Holdings Pty Ltd. Her executive career includes almost 30 years as a strategy management consultant, where she focused on financial services, health and consumer product industries, including co-leading the Booz & Company business in Japan for 4 years. Earlier in her career she was a Portfolio Manager with Investment Bank Schroders. Ms Wallace is an early-stage investor in the health sector and the founding Chairman of Australian digital health & biotechnology business, Drop Bio Pty Ltd.

Professor Bruce Gregory Robinson Non-Executive Director Mar 2021

Professor Bruce Gregory Robinson

Non-Executive Director

Prof Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlear, an ASX listed global hearing implants business; MaynePharma, an ASX listed pharmaceutical manufacturer; and QBiotics, a drug development company. Since 2015 Prof Robinson has also chaired the Australian Government's National Health and Medical Research Council, and the Medical Benefits Schedule Review Task Force. His prior professional experience includes Dean of University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. The summary of his experience is as follows: 2015 - present: Chair of the National Health and Medical Research Council; 2015 - present: Chair of the Medical Benefits Schedule Review Taskforce; 2007 - 2016: Dean, Sydney Medical School; 1998 - 2006: Head, Division of Medicine, Royal North Shore Hospital; 1990 - 2008: Head, Cancer Genetics Laboratory, Kolling Institute for Medical Research. Boards experience includes : Cochlear, 2015 - present; QBiotics, 2015 - present; MaynePharma, 2014 - present; and Woolcock Institute, 2006 - present.

Mr Jonathan Cedric Mengel Brown Chief Financial Officer,Company Secretary Jan 2021
Ms Robin Sheldon General Counsel,Joint Company Secretary Jan 2021
Ms Kristi Woolrych Non-Executive Director Oct 2020

Ms Kristi Woolrych

Non-Executive Director

Ms Woolrych has over 20 years' experience in brand strategy, acquisition, retention, customer experience, eCommerce and retail marketing in a various of industries. She is currently the Chief Marketing Officer for KFC in Australia and New Zealand. Her experience include at KFC across the last two years and brand performance, resulting in APAC Effie Awards for Brand of the Year and Marketing Team of the Year in 2020. Prior to KFC, Ms Woolrych worked at Suncorp for over a decade, where she was promoted to the position of Executive General Manager, Brand and Marketing. During her carree she holds following position: 2018-Present Chief Marketing Officer, KFC SOPAC; 2016-2018 Executive General Manager Brand and Marketing, Suncorp; 2015-2016 Executive General Manager Group Marketing, Suncorp; 2013-2015 Executive Manager Brand and Customer Strategy, Suncorp; 2010-2013 Executive Manager Strategic Marketing and Insights, Suncorp; 2007-2010 Executive Manager Digital Marketing, Suncorp; and Other Experience MojoPartners (Publicis); Clemenger BBDO. She has completed a range of postgraduate programs including the Harvard Business School Digital Masterclass, INSEAD CMO Academy and Australian Marketing Institute Advanced Strategic Planning.

Mr Jonathan (Jon) Peter Meadmore Non-Executive Director Oct 2017

Mr Jonathan (Jon) Peter Meadmore

Non-Executive Director

Mr Meadmore is a Brisbane-based partner of law firm, Colin Biggers & Paisley. He is the joint leader of the corporate group, having practiced law for over 25 years.

Mr Eric Tse Wang Chief Executive Officer,Managing Director Nov 2015

Mr Eric Tse Wang

Chief Executive Officer,Managing Director

Mr Wang has over 25 years of leadership and executive management experience, both as an officer in the United States Army and as a financial services executive in Australia. Prior to joining Ecofibre, Eric served as Captain and Apache pilot in the US Army for eight years in a range of roles, including Troop Commander, Operations Officer, Executive Officer and Personnel Officer in the United States and Europe.

Director Transactions

EOF directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
04/03/22 Eric Tse Wang Buy +1,000,000 $0.435 $434,600 On-market trade
28/02/22 Vanessa Wallace Buy +250,000 $0.405 $101,250 On-market trade
13/12/21 Bruce Robinson Buy +30,000 $0.55 $16,500 On-market trade
01/12/21 Bruce Robinson Issued 144,750 $0.67 $96,982 Issue of options
01/12/21 Jonathan (Jon) Meadmore Issued 173,700 $0.67 $116,379 Issue of options
01/12/21 Kristi Woolrych Issued 144,750 $0.67 $96,982 Issue of options
01/12/21 Vanessa Wallace Issued 386,001 $0.67 $258,620 Issue of options
11/12/20 Eric Tse Wang Buy +350,000 $2.129 $745,182 On-market trade
21/08/20 Barry Lambert Sell +51,204 $2.80 ($143,371) On-market trade
19/02/20 Barry Lambert Sell +2,000,000 $2.74 ($5,480,000) Off-market trade
19/02/20 Barry Lambert Sell +2,000,000 $2.74 ($5,480,000) Off-market trade
30/09/19 Barry Lambert Buy +5,148,223 $0.257 $1,321,377 Conversion of securities

Director Interests

The current holdings of EOF directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Michele Anderson 14/03/2022 0 N/A N/A N/A
Eric Tse Wang 04/03/2022 9,994,158 4,284,423 N/A N/A
Vanessa Wallace 28/02/2022 500,000 N/A 386,001 N/A
Bruce Robinson 13/12/2021 0 30,000 144,750 N/A
Kristi Woolrych 01/12/2021 0 N/A 144,750 N/A
Jonathan (Jon) Meadmore 01/12/2021 N/A 538,000 173,700 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 5, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Barjoy Pty Ltd 37,688,454 11.05%
Barry Martin Lambert & Joy Wilma Lillian Lambert 34,497,242 10.12%
Phil Warner Pty Ltd 32,481,381 9.52%
HSBC Custody Nominees (Australia) Limited 25,820,376 7.57%
Freshwater Superannuation Fund Pty Limited 20,089,149 5.89%
Kylie Warner Pty Ltd 16,340,072 4.79%
Thomas Jefferson University 12,178,259 3.57%
Eric Wang 8,644,158 2.53%
Citicorp Nominees Pty Limited 7,664,587 2.25%
Pacific Custodians Pty Limited (Employee Securities Tst Unallocated A/C) 7,200,000 2.11%
Pacific Custodians Pty Limited (Employee Securities Tst A/C) 6,909,286 2.03%
Wow Corporate Pty Ltd 6,648,700 1.95%
Texsymmetry Inc 6,595,959 1.93%
Jeffrey Bruner 5,400,148 1.58%
John Ryan 5,311,786 1.56%
Manderrah Pty Limited 5,243,369 1.54%
Walling Pty Limited 4,850,181 1.42%
National Nominees Limited 3,163,706 0.93%
Yarrawonga Holdings Pty Limited (Yarrawonga Super Fund A/C) 3,048,553 0.89%
Troncell Pty Ltd 2,922,078 0.86%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 2,336 1,760 561 744 123 5,524

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Barry Martin Lambert 05/08/2021 74,236,900 23.57
Phillip Warner 05/08/2021 53,109,243 17.17
James William Vicars 05/08/2021 30,841,174 9.97
Perennial Value Management Limited 28/10/2021 26,276,118 7.53

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
28-10-21 Perennial Value Management Limited 4,235,480 6.46 7.53
02-09-21 Perennial Value Management Limited 22,040,638 -- 6.46

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.66 30 June
2020 $2.22 30 June
2019 $2.10 28 June
EOF Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.